Purpose
to support the generation of Respiratory syncytial virus (RSV) burden data to inform country decision-making on Respiratory syncytial virus (RSV) vaccine adoption in priority low and middle income countries
Grantee
Division
Global Health
Date
NOVEMBER 2024
Region served
AFRICA,
AMERICA,
ASIA
Committed amount
$3,299,943
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
36
Grantee location
Atlanta, Georgia, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.